You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 4, 2024

AVENTYL Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Aventyl, and when can generic versions of Aventyl launch?

Aventyl is a drug marketed by Ranbaxy and Lilly and is included in two NDAs.

The generic ingredient in AVENTYL is nortriptyline hydrochloride. There are twelve drug master file entries for this compound. Twenty-eight suppliers are listed for this compound. Additional details are available on the nortriptyline hydrochloride profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Aventyl

A generic version of AVENTYL was approved as nortriptyline hydrochloride by DR REDDYS LABS SA on March 30th, 1992.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for AVENTYL?
  • What are the global sales for AVENTYL?
  • What is Average Wholesale Price for AVENTYL?
Summary for AVENTYL
Drug patent expirations by year for AVENTYL
Recent Clinical Trials for AVENTYL

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Central Michigan UniversityN/A
Sheppard Pratt Health SystemN/A

See all AVENTYL clinical trials

US Patents and Regulatory Information for AVENTYL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ranbaxy AVENTYL nortriptyline hydrochloride SOLUTION;ORAL 014685-001 Approved Prior to Jan 1, 1982 DISCN Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Lilly AVENTYL HYDROCHLORIDE nortriptyline hydrochloride CAPSULE;ORAL 014684-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Lilly AVENTYL HYDROCHLORIDE nortriptyline hydrochloride CAPSULE;ORAL 014684-002 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.